Informative gene network for chemotherapy-induced peripheral neuropathy

Area of Science:

• Genomics
• Bioinformatics
• Neuroscience

Background:

• Host genetic variability plays a role in chemotherapy-induced peripheral neuropathy (CIPN).
• CIPN is a dose-limiting toxicity of chemotherapy and can lead to chronic neuropathic pain.
• Identifying genetic factors is crucial for understanding and managing CIPN.

Purpose of the Study:

• To identify genes associated with chemotherapy-induced peripheral neuropathy (CIPN) using a bioinformatics approach.
• To explore the complex intracellular and intercellular interactions involved in CIPN development.
• To uncover genetic targets for mitigating CIPN in cancer patients.

Main Methods:

• Utilized Ingenuity Pathway Analysis (IPA) to generate gene networks for CIPN.
• Performed IPA core analysis on genes linked to platinum, taxane, and combined platinum-taxane-induced neuropathy.
• Leveraged existing literature to compile an initial set of relevant genes.

Main Results:

• Identified top genes for platinum-induced neuropathy: IL6, TNF, CXCL8, IL1B, and ERK1/2.
• Identified top genes for combined taxane-platinum-induced neuropathy: TP53, MYC, PARP1, P38 MAPK, and TNF.
• Highlighted the significant connectivity of these genes within neuropathy-related pathways.

Conclusions:

• Neurotoxicity, including CIPN, is a frequent complication in cancer patients treated with platinum compounds and anti-microtubule agents.
• The bioinformatics approach successfully identified key genes implicated in CIPN.
• These findings contribute to understanding the genetic basis of CIPN and may inform future therapeutic strategies.